Veterinary Medicines

AQUPHARM RINGER LACTATE SOLUTION FOR INFUSION

Authorised
  • Sodium chloride
  • Sodium lactate
  • Calcium chloride
  • Potassium chloride
Download as PDF

Product identification

Medicine name:
AQUPHARM RINGER LACTATE SOLUTION FOR INFUSION
Aqupharm Ringer-Lactate infuusioneste, liuos
Active substance:
  • Sodium chloride
  • Sodium lactate
  • Calcium chloride
  • Potassium chloride
Target species:
  • Cattle
  • Pig
  • Rabbit
  • Cat
  • Horse
  • Sheep
  • Goat
  • Dog
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Sodium chloride
    6.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium lactate
    3.20
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium chloride
    0.22
    milligram(s)
    /
    1.00
    millilitre(s)
  • Potassium chloride
    0.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Pig
      • Meat and offal
        0
        day
    • Rabbit
      • Meat and offal
        0
        day
    • Cat
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB05BB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Finland
Available in:
  • Finland
Package description:
  • Cardboard box containing 20 bags of 500 ml
  • Cardboard box containing 10 bags of 1000 ml
  • Cardboard box containing 4 bags of 3000 ml
  • Cardboard box containing 2 bags of 5000 ml
  • Cardboard box containing 30 bags of 250 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
  • Infomed Fluids S.r.l.
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 33640
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0303/001
Concerned member states:
  • Belgium
  • Finland
  • Hungary
  • Iceland
  • Ireland
  • Netherlands
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 29/11/2023
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 29/11/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."